. Adult human beta cells fail to replicate in response to three days of PRL treatment. Immunofluorescent labeling in rat and adult human islet cells showing BrdU incorporation and Ki67 immunolabeling with or without 400 ng/ml PRL treatment for three days. As positive controls, human breast cancer cells, MCF-7, T47D cells (A), as well as primary cultures of rat beta cells (B, upper panels) respond to PRL stimulation with increased BrdU incorporation. In contrast, human beta (B, lower panels) do not respond to prolactin with replication. Similar results were obtained in repeated experiments from 4-6 independent human donors. Six day studies are shown in Fig 3A-C. Supplementary Figure 3 . Relative mRNA levels of negative regulators of human PRL-R signaling pathways in adult human islets. The mRNA levels of indicated genes in primary islets, normal human mammary epithelial cells (Mam. Epi), and human cancer cell lines were measured by real-time RT-PCR. See the legend to Fig 3D for details. Three to 10 human samples were analyzed for each group. The red bars depict the mean value of all measurements. Except SOCS1, 3 and 5, most of the negative regulators of JAK-STAT signaling are not notably increased in human islets.
Supplementary Figure 4. Immunofluorescent labeling of human PRLR in adult human islet endocrine cells from dispersed islets (A) and intact pancreas (B).
Human PRLR is undetectable in insulin + beta cells and somatostatin + delta cells; in contrast, it is readily visualized in subpopulations of glucagon + alpha cells and pancreatic polypeptide + PP cells. Similar results were obtained from repeated experiments from 4-6 independent human islet donors or 4 human pancreas donors. White bar 25 m.
Supplementary Figure 5. Adult human beta cells express GHR. (A)
Immunofluorescent staining of GHR in intact adult human pancreas sections, dispersed adult human islets, and T47D cells. The GHR antibody was raised by S.J.F, and specifically detects GHR protein, as revealed by no GHR labeling in pancreas sections or islets treated with control non-immune rabbit serum. Note that, unlike PRLR protein which is absent in beta cells ( Figs 3E,F) , GHR expression is readily detectable in insulin + beta cells in the intact adult human pancreas as well as dispersed islets. Supplementary Figure 6. Real-time RT-PCR analyses of STAT5A, STAT5B (A) and PIAS mRNAs (B) in adult human islets with reconstituted human PRLR. Dispersed human islets were transduced with 200 MOI Ad.PRLR or control adenovirus (Ad.LacZ) for 48 hrs, followed by treatment without or with 300 ng/ml PRL for 72 hrs, and then RT-PCR assays for the indicated genes. Data are depicted as mean ± SE, and include four independent islet donors for each group. * p<0.05, ** p<0.01 vs. Ad.LacZ without PRL treatment. Supplementary Figure 7 . Amino acid sequence comparison of human, chimpanzee, rat and mouse STAT5A proteins. Human STAT5A share approximately 96% homology in amino acids with rodent Stat5a, but also contain significant numbers of amino acids (highlighted in red), mainly located in N-terminal and C-terminal of STAT5A protein, that differ from rodent Stat5a. Whether the functional difference between human STAT5A and mouse Stat5a in adult human beta cell replication stems from these different amino acid sequences is unknown.
